AdventHealth launches first-of-its-kind immunotherapy treatment, clinical trial for specific blood cancer patients
AdventHealth physicians are the first in the world to launch a pioneering treatment targeting certain blood cancers for patients who have exhausted all other types of therapy. Antigen-Specific T-Cell therapy, which is the subject of a clinical trial at AdventHealth Orlando, uses the immune cells ...





